VSee Health, Inc. (VSEEW)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
VSee Health, Inc. (VSEEW) trades at $0.03 with AI Score 49/100 (Grade C). VSee Health, Inc. offers telehealth solutions, focusing on acute care coordination through its iDoc Telehealth platform. Market cap: $2.55M, Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for VSEEW: VSEEW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VSEEW against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
VSEEW: the 1 perspectives are evenly split.
VSee Health, Inc. (VSEEW) Healthcare & Pipeline Overview
VSee Health, Inc. specializes in telehealth solutions, providing its iDoc Telehealth platform for acute care coordination in critical care units. With a focus on neurointensive and cardiac intensive care, VSee Health aims to improve patient outcomes through technology, operating in the competitive healthcare information services sector.
What Is the Investment Thesis for VSEEW?
VSee Health, Inc. presents a focused investment opportunity within the telehealth sector, targeting acute care coordination through its iDoc Telehealth platform. With a negative P/E ratio of -0.36 and a negative profit margin of -85.8%, the company is currently not profitable, indicating potential for growth and efficiency improvements. The gross margin of 54.6% suggests a viable business model if operational costs can be managed effectively. Key value drivers include expanding the adoption of the iDoc Telehealth platform in hospitals and critical care units. Growth catalysts include potential partnerships with healthcare systems and regulatory tailwinds supporting telehealth adoption. Potential risks include competition from larger telehealth providers and the need for continuous innovation to maintain a competitive edge. The company's small size, with only 2 employees, presents both opportunities for rapid growth and challenges in scaling operations.
Based on FMP financials and quantitative analysis
VSEEW Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with significant growth potential and associated risks.
- P/E ratio of -0.36 reflects current unprofitability, suggesting potential for future earnings growth.
- Profit margin of -85.8% highlights the need for improved cost management and revenue generation.
- Gross margin of 54.6% demonstrates the potential for profitability with effective operational management.
- Beta of 0.50 suggests lower volatility compared to the market, potentially appealing to risk-averse investors.
Who Are VSEEW's Competitors?
VSEEW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMWL American Well Corporation (AMWL) | $9.19 | +0.33% | $153.55M | 52 |
| APYX Apyx Medical Corporation | $4.65 | +0.87% | $194.71M | 49 |
| CCLD CareCloud, Inc. | $2.33 | +0.65% | $99.22M | 53 |
| EUDA EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical | $16.00 | +6.52% | $29.88M | 46 |
| JYNT The Joint Corp. | $9.10 | +7.95% | $129.72M | 51 |
| CARL CARLSMED, INC. | $11.43 | -1.68% | $310.59M | 70 |
| HNGE Hinge Health, Inc. | $65.34 | +0.91% | 6B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.05 | +7.08% | $21.00M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VSEEW's Key Strengths?
- Specialized telehealth solutions for acute care.
- Proprietary iDoc Telehealth platform.
- Focus on critical care environments.
- Potential for high growth in the telehealth market.
What Are VSEEW's Weaknesses?
- Small company size with limited resources.
- Negative profitability and profit margin.
- Dependence on a single platform (iDoc Telehealth).
- Limited market presence compared to larger competitors.
What Could Drive VSEEW Stock Higher?
- Increased adoption of telehealth solutions due to the COVID-19 pandemic.
- Potential partnerships with healthcare systems to integrate the iDoc Telehealth platform.
- Development and launch of new AI-powered features for the iDoc Telehealth platform.
- Expansion into new geographic markets, such as Europe and Asia.
What Are the Key Risks for VSEEW?
- Competition from larger, more established telehealth providers.
- Regulatory changes and compliance requirements affecting the telehealth industry.
- Technological obsolescence and the need for continuous innovation.
- Negative profitability and profit margin.
- Dependence on a single platform (iDoc Telehealth).
What Are the Growth Opportunities for VSEEW?
- Expansion into New Therapeutic Areas: VSee Health can expand its iDoc Telehealth platform to support additional therapeutic areas beyond neurointensive and cardiac intensive care. This includes exploring applications in areas such as oncology, geriatrics, and post-operative care. The market for telehealth in these areas is substantial, with a potential market size exceeding $10 billion by 2030. This expansion would require adapting the platform to meet the specific needs of each therapeutic area, including developing new monitoring tools and care protocols. The timeline for this expansion could be phased over the next 3-5 years.
- Geographic Market Expansion: VSee Health can expand its geographic reach beyond its current focus in the United States. This includes targeting international markets such as Europe, Asia, and Latin America, where there is a growing demand for telehealth solutions. The global telehealth market is projected to reach $550 billion by 2030, presenting significant opportunities for growth. This expansion would require adapting the platform to meet local regulatory requirements and cultural preferences. The timeline for this expansion could be phased over the next 5-7 years.
- Partnerships with Healthcare Systems: VSee Health can form strategic partnerships with healthcare systems to integrate its iDoc Telehealth platform into their existing workflows. This includes partnering with hospitals, clinics, and physician groups to offer telehealth services to their patients. These partnerships would provide VSee Health with access to a larger customer base and increased revenue opportunities. The market for telehealth partnerships is estimated to be worth $5 billion by 2028. The timeline for establishing these partnerships could be initiated within the next 1-2 years.
- Development of AI-Powered Solutions: VSee Health can leverage artificial intelligence (AI) to enhance its iDoc Telehealth platform. This includes developing AI-powered tools for remote patient monitoring, diagnosis, and treatment planning. AI can improve the efficiency and accuracy of telehealth services, leading to better patient outcomes. The market for AI in healthcare is projected to reach $45 billion by 2027. The timeline for developing these AI-powered solutions could be phased over the next 2-4 years.
- Integration with Wearable Devices: VSee Health can integrate its iDoc Telehealth platform with wearable devices to enable remote patient monitoring and data collection. This includes integrating with devices such as smartwatches, fitness trackers, and medical sensors to collect data on patients' vital signs, activity levels, and sleep patterns. This data can be used to personalize telehealth services and improve patient outcomes. The market for wearable medical devices is projected to reach $30 billion by 2028. The timeline for integrating with wearable devices could be initiated within the next 1-2 years.
What Opportunities Does VSEEW Have?
- Expansion into new therapeutic areas.
- Geographic market expansion.
- Partnerships with healthcare systems.
- Development of AI-powered solutions.
What Threats Does VSEEW Face?
- Competition from larger, more established telehealth providers.
- Regulatory changes and compliance requirements.
- Technological obsolescence.
- Economic downturn affecting healthcare spending.
What Are VSEEW's Competitive Advantages?
- Specialized focus on acute care coordination.
- Proprietary iDoc Telehealth platform.
- Expertise in neurointensive and cardiac intensive care.
What Does VSEEW Do?
VSee Health, Inc., headquartered in Newton, Massachusetts, is a telehealth company focused on delivering solutions for acute care coordination. The company's core offering, the iDoc Telehealth platform, is designed to treat and coordinate care for acutely ill patients, particularly those in neurointensive care, cardiac intensive care, and intensive care units. These solutions address critical conditions such as stroke, spinal cord injuries, brain trauma, and other neurological conditions. Founded to leverage technology in improving healthcare delivery, VSee Health aims to provide a set of building blocks that can be customized to meet the specific needs of its clients. The company's telehealth platform enables remote monitoring, consultation, and collaboration among healthcare providers, facilitating timely and effective interventions. VSee Health's focus on specialized care distinguishes it within the broader telehealth market, positioning it to address the complex needs of critical care environments. Despite its innovative approach, VSee Health faces competition from larger, more established telehealth providers and must navigate the regulatory landscape to ensure compliance and market access.
What Products and Services Does VSEEW Offer?
- Provides telehealth care solutions.
- Offers iDoc Telehealth solutions for acute care coordination.
- Treats patients in neurointensive care units.
- Treats patients in cardiac intensive care units.
- Treats patients in intensive care units.
- Addresses conditions like stroke, spinal cord injuries, and brain trauma.
- Offers a telehealth platform with customizable building blocks.
How Does VSEEW Make Money?
- Provides a telehealth platform to healthcare providers.
- Generates revenue through licensing fees for its iDoc Telehealth platform.
- Offers customized telehealth solutions tailored to client needs.
What Industry Does VSEEW Operate In?
VSee Health, Inc. operates within the rapidly expanding telehealth industry, which has seen significant growth due to increased demand for remote healthcare services. The market is driven by factors such as an aging population, rising healthcare costs, and advancements in technology. The competitive landscape includes established players like AMWL and emerging telehealth providers. VSee Health's focus on acute care coordination positions it within a niche segment of the market, potentially offering a competitive advantage. The telehealth market is projected to continue growing, presenting opportunities for VSee Health to expand its market share.
Who Are VSEEW's Key Customers?
- Hospitals
- Intensive Care Units
- Healthcare Providers
VSEEW Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
VSEEW Latest News
No recent news available for VSEEW.
VSEEW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VSEEW.
Price Targets
Wall Street price target analysis for VSEEW.
VSEEW MoonshotScore
What does this score mean?
The MoonshotScore rates VSEEW's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Milton Chen
CEO
Milton Chen is the CEO of VSee Health, Inc. He is responsible for managing the company's overall strategy and operations. With a background in technology and healthcare, Chen brings a unique perspective to the telehealth industry. He has experience in developing and commercializing innovative healthcare solutions. Chen's leadership is focused on driving growth and expanding the reach of VSee Health's iDoc Telehealth platform.
Track Record: Under Milton Chen's leadership, VSee Health, Inc. has focused on developing its iDoc Telehealth platform and expanding its reach in the acute care market. Key milestones include securing partnerships with hospitals and healthcare systems to implement the platform. Chen has also overseen the development of new features and capabilities for the platform, including AI-powered tools for remote patient monitoring.
VSEEW Healthcare Stock FAQ
What does VSee Health, Inc. do?
VSee Health, Inc. provides telehealth solutions, primarily through its iDoc Telehealth platform, which focuses on acute care coordination. The company's platform is designed to treat and coordinate care for acutely ill patients in critical care units, such as neurointensive and cardiac intensive care units. VSee Health's solutions address conditions like stroke, spinal cord injuries, and brain trauma, offering a customizable platform to meet the specific needs of healthcare providers. The company aims to improve patient outcomes and enhance healthcare delivery through technology.
What are the main risks for VSEEW?
VSee Health, Inc. faces several risks, including competition from larger telehealth providers, regulatory changes affecting the telehealth industry, and the need for continuous innovation to stay competitive. The company's negative profitability and profit margin also pose significant challenges. Dependence on a single platform (iDoc Telehealth) and limited market presence further increase the company's vulnerability. Economic downturns affecting healthcare spending could also impact VSee Health's growth prospects. Investors should carefully consider these risks before investing in VSEEW.
What are the key factors to evaluate for VSEEW?
VSee Health, Inc. (VSEEW) holds an AI score of 49/100 (low). Not financial advice.
How frequently does VSEEW data refresh on this page?
VSEEW prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven VSEEW's recent stock price performance?
VSee Health, Inc. (VSEEW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized telehealth solutions for acute care. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VSEEW overvalued or undervalued right now?
Valuing VSee Health, Inc. (VSEEW) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying VSEEW?
Before investing in VSee Health, Inc. (VSEEW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding VSEEW to a portfolio?
Key strength of VSee Health, Inc. (VSEEW): Specialized telehealth solutions for acute care. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on VSee Health, Inc.
- AI analysis pending for VSEEW.